75338-17-9

Basic information

• Product Name: TETRAHYDRO-BETA-OXO-2H-PYRAN-4-PROPANOIC ACID METHYL ESTER
• Synonyms: TETRAHYDRO-BETA-OXO-2H-PYRAN-4-PROPANOIC ACID METHYL ESTER;Methyl 3-oxo-3-(oxan-4-yl)propanoate
• CAS NO: 75338-17-9
• Molecular Formula: C9H14O4
• Molecular Weight: 186.206
• Mol File: 75338-17-9.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 271.2±30.0 °C(Predicted)
• Appearance: /
• Density: 1.126±0.06 g/cm3(Predicted)
• PKA: 10.30±0.20(Predicted)
• CAS DataBase Reference: TETRAHYDRO-BETA-OXO-2H-PYRAN-4-PROPANOIC ACID METHYL ESTER(CAS DataBase Reference)
• NIST Chemistry Reference: TETRAHYDRO-BETA-OXO-2H-PYRAN-4-PROPANOIC ACID METHYL ESTER(75338-17-9)
• EPA Substance Registry System: TETRAHYDRO-BETA-OXO-2H-PYRAN-4-PROPANOIC ACID METHYL ESTER(75338-17-9)

Safety Data

• Hazardous Substances Data: 75338-17-9(Hazardous Substances Data)

Upstream product

• 5337-03-1 tetrahydro-2H-pyran-4-carboxylic acid 
• 67-56-1 methanol 
• 110238-91-0 tetrahydropyran-4-carboxylic acid methyl ester 
• 38330-80-2 monomethyl monopotassium malonate 
• 137052-08-5 1-(tetrahydro-2H-pyran-4-yl)ethan-1-one 
• 616-38-6 carbonic acid dimethyl ester 

Relevant articles and documents

HETEROARYLDIHYDROPYRIMIDINE DERIVATIVES AND METHODS OF TREATING HEPATITIS B INFECTIONS

Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.

AMINE-SUBSTITUTED ARYL OR HETEROARYL COMPOUNDS AS EHMT1 AND EHMT2 INHIBITORS

The present disclosure relates to amine-substituted aryl or heteroaryl compounds. The present disclosure also relates to pharmaceutical compositions containing these compounds and methods of treating a disorder (e.g., sickle cell anemia) via inhibition of a methyltransferase enzyme selected from EHMT1 and EHMT2, by administering an amine-substituted aryl or heteroaryl compound disclosed herein or a pharmaceutical composition thereof to subjects in need thereof. The present disclosure also relates to the use of such compounds for research or other non-therapeutic purposes.

2-SUBSTITUTED-3-(4-TETRAHYDROPYRANYL)-3-OXOPROPANOIC ESTER AND PROCESS FOR PRODUCING THE SAME

This invention provides a 2-substituted-3-(4-tetrahydropyranyl)-3-oxopropanoic ester represented by general formula (1) wherein Y represents a halogen atom or an acyloxy group, and R represents a hydrocarbon group, and a process for producing the same.